Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...

Experts say the drugs are safe and effective. Shortly after Robert F. Kennedy Jr. was sworn in as secretary of the Department of Health and Human Services, President Donald Trump issued an ...

Novo Nordisk (NVO) stock was down more than 8% Monday morning ... is being tested for obesity and Type 2 diabetes as a once-weekly injectable. Results from the Phase 3 trial show weight loss ...

Understanding why we always have room for dessert could lead to new treatments for obesity, researchers have revealed.

Browse 1,400+ obesity clipart stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art. Dieting Thin Line Icons - ...

Find Pet Obesity stock video, 4K footage, and other HD footage from iStock. Get higher quality Pet Obesity content, for less—All of our 4K video clips are the same price as HD. Video Back Videos home ...

Viking is set to challenge Eli Lilly and Novo Nordisk with its investigational oral obesity drug. Credit: SOPA Images via Getty Images ... demand once on the market,” she added. Viking’s stock fell 12 ...

Insomnia is a brutal condition (Getty Stock Images) Dr Fatema Al-Rashed ... help mitigate the burden of inflammatory diseases like obesity, diabetes, and cardiovascular diseases." ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5. ... The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on ...

China’s health ministry outlined a range of measures, including urging hotels to install scales, to address the country’s ...

Obesity genes that cause dogs to pile on the pounds have been identified, with the same genes associated with obesity in ...

Amgen (NASDAQ:AMGN) stock in focus as company starts Phase 3 trials for obesity drug MariTide, aiming to challenge Eli Lilly ...